Airway & Compression Techniques for Cardiac Arrest
(FACT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve treatments for individuals experiencing sudden out-of-hospital cardiac arrest, where the heart stops beating outside a hospital. It compares two breathing techniques used during emergency care: one with a bag valve mask (BVM) and the other with an i-gel device, a type of airway management device, to determine which improves survival rates. The trial also examines different chest compression rates during CPR to identify the most effective pace. Adults in Seattle and King County who experience sudden cardiac arrest and receive basic life support from emergency responders may meet the trial criteria. As an unphased trial, this study allows participants to contribute to vital research that could enhance emergency care for cardiac arrest patients.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that these airway and compression techniques are safe for cardiac arrest patients?
Research shows that both the i-gel device and certain chest compression rates used in CPR are safe for people. The i-gel assists breathing when someone cannot breathe independently. Studies have found that paramedics find the i-gel easy to use and effective in delivering air to the lungs.
For chest compressions during CPR, research suggests that about 107 compressions per minute is ideal. This pace helps blood flow to the brain and heart during an emergency. Other studies indicate that a slightly faster rate, between 121 and 140 compressions per minute, can also improve survival chances.
Both the i-gel and the chest compression rates tested in this trial are already used in real-life emergencies by medical professionals. They are generally well-tolerated and considered safe.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores new ways to improve outcomes in cardiac arrest situations. Unlike standard practices that focus on a universal chest compression rate and basic airway management techniques, this trial looks at varying compression rates (100, 110, and 120 compressions per minute) and compares two airway strategies: the traditional bag-valve-mask (BVM) and the i-gel device. The i-gel is particularly interesting because it’s designed for a quick and easy fit, potentially offering more effective airway management without the need for complex procedures. By testing these variables, researchers hope to discover optimal techniques that could enhance survival rates and recovery in cardiac arrest cases.
What evidence suggests that this trial's treatments could be effective for sudden cardiac arrest?
In this trial, participants will join different treatment arms to evaluate the effectiveness of various chest compression rates and airway strategies during cardiac arrest. Research has shown that the speed of chest compressions doesn't greatly affect survival rates for sudden cardiac arrest (SCA). However, one study suggested that performing about 107 compressions per minute might be optimal when paired with a certain depth. Participants in the compression rate arm will experience one of three chest compression rates: 100, 110, or 120 compressions per minute.
For the airway strategy arm, participants will receive treatment with either the BVM or the i-gel airway device. Studies indicate that the i-gel is easy to insert successfully and may lead to better outcomes than other airway tools. The i-gel is also known for being cost-effective and efficient in emergencies. Overall, both the chest compression rate and the i-gel device meet established guidelines, making them reliable options for standard care.46789Who Is on the Research Team?
Thomas Rea, MD
Principal Investigator
University of Washington
Are You a Good Fit for This Trial?
This trial is for adults in Seattle and greater King County who experience a sudden, non-traumatic cardiac arrest outside of the hospital where EMS will attempt resuscitation.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive basic life support treatments including rescue breathing with either BVM or i-gel and chest compressions at varying rates
Follow-up
Participants are monitored for survival to hospital discharge and neurological function
What Are the Treatments Tested in This Trial?
Interventions
- Compression Rate
- i-gel
Compression Rate is already approved in United States, European Union, Canada for the following indications:
- Cardiac arrest
- Sudden circulatory collapse
- Out-of-hospital cardiac arrest
- Cardiac emergency
- Sudden cardiac arrest
- Cardiopulmonary emergency
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor